Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Nutr Health Aging ; 24(9): 1023-1030, 2020.
Article in English | MEDLINE | ID: mdl-33155632

ABSTRACT

OBJECTIVES: The purpose of this study was to examine if there is a relationship between lower-extremity muscle performance (LEMP) and physical activity, especially the physical activity level (PAL) value, in community-dwelling middle-aged and older adults. DESIGN: Cross-sectional study. SETTING: Community-based. PARTICIPANTS: Participants were 54 community-dwelling and independent middle-aged and older individuals (aged 54-89 years). MEASUREMENTS: Physical activity level was calculated from the total energy expenditure of each participant obtained using the doubly labeled water method (PALDLW) and estimated basal metabolic rate. Daily step count and intensity of physical activity was monitored with a triaxial accelerometer, and LEMP was assessed using the five-repetition sit-to-stand test (STS-5) and vertical jumping (VJ). RESULTS: The results of STS-5 nearly negatively correlated with those of PALDLW when analysing the middle-aged and older man and woman, separately. VJ positively correlated with PALDLW when analysing the middle-aged and older men and woman, separately. The relationship between LEMP (e.g. STS-5 and VJ) and PAL were maintained, regardless of sex and body composition. PALDLW was significantly positively correlated with LPA, MVPA, and steps, and significantly negatively correlated with sedentary time. The relationship PALDLW and steps was described as following equation: PALDLW = 0.0000392 × steps +1.531. CONCLUSIONS: These findings suggest that PALDLW is a key contributor to increasing LEMP among middle-aged and older adults. Maintaining high PALDLW may be beneficial to independent living, and participation in recreational and social activities in middle-aged and older adults.


Subject(s)
Accelerometry/methods , Exercise/physiology , Lower Extremity/physiopathology , Muscles/physiopathology , Water/metabolism , Aged , Aged, 80 and over , Cross-Sectional Studies , Female , Humans , Male , Middle Aged
2.
Chem Biodivers ; 8(11): 2144-8, 2011 Nov.
Article in English | MEDLINE | ID: mdl-22083927

ABSTRACT

Hydrodistallation of the aerial parts of Nepeta transcaucasica Grossh. (Lamiaceae), collected in Agri, Dogubayazit Province, afforded an essential oil that was characterized by GC and GC/MS analyses. Twenty-seven compounds, representing 97.69% of the total oil composition, were identified, and 4aα,7α,7aß-nepetalactone (1; 39%), 4aα,7α,7aα-nepetalactone (2; 28%), and germacrene D (3; 15%) constituted the major components. The anticandidal effects of the oil were evaluated against seven Candida strains by using the broth microdilution method. The oil showed good inhibitory effects against C. glabrata and C. tropicalis at minimal inhibitory concentrations (MICs) of 0.09 and 0.375 mg/ml, respectively.


Subject(s)
Antifungal Agents/isolation & purification , Candida/drug effects , Nepeta/chemistry , Oils, Volatile/isolation & purification , Plant Oils/isolation & purification , Antifungal Agents/pharmacology , Candida/growth & development , Gas Chromatography-Mass Spectrometry , Microbial Sensitivity Tests , Molecular Structure , Nepeta/growth & development , Oils, Volatile/pharmacology , Plant Components, Aerial/chemistry , Plant Components, Aerial/growth & development , Plant Oils/pharmacology
3.
Fitoterapia ; 78(3): 253-4, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17329038

ABSTRACT

Composition of the water-distilled oil of the aerial parts of Centaurea aladagensis, endemic in Turkey, was analysed by GC-MS. Hexadecanoic acid (39.3%), caryophyllene oxide (6.6%) and hexahydrofarnesyl acetone (4.3%) were found as main constituents in the oil. The oil was tested against 7 human pathogenic microorganisms.


Subject(s)
Anti-Infective Agents/pharmacology , Centaurea , Phytotherapy , Plant Oils/pharmacology , Staphylococcus epidermidis/drug effects , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/chemistry , Anti-Infective Agents/therapeutic use , Chromatography, Gas , Humans , Mass Spectrometry , Microbial Sensitivity Tests , Plant Components, Aerial , Plant Oils/administration & dosage , Plant Oils/chemistry , Plant Oils/therapeutic use
5.
Eur J Anaesthesiol ; 19(2): 125-8, 2002 Feb.
Article in English | MEDLINE | ID: mdl-11999595

ABSTRACT

BACKGROUND AND OBJECTIVE: The effects of remifentanil, alfentanil and fentanyl were compared on cardiovascular responses to laryngoscopy and endotracheal intubation in morbidly obese patients. METHODS: Eighty morbidly obese ASA I-II patients were included in the study. Patients were randomly divided into four groups to receive either 1 microgkg(-1) fentanyl (Group F), 10 microgkg(-1) alfentanil (A), 1 microgkg(-1) followed by an infusion of 0.5 pg kg min(-1) remifentanil (R) or saline (P). The patients corrected weight was used to calculate the drug doses. Body mass indices (range) were: 54.3 +/- 7.37 (49-78.4), 55.67 +/- 7.44 (48.5-78.4), 53.17 +/- 5.36 (48.1-63.2), and 56.3 +/- 6.09 (46.6-67.7) kg m(-2), in Groups F, R, A and P respectively. Systolic, diastolic and mean arterial pressures and heart rate were measured non-invasively at three time points, which were 2 min before induction, 2 min after induction and 2 min after endotracheal intubation. RESULTS: After induction of anaesthesia, arterial pressures decreased significantly in all groups, but the decrease was more pronounced in Groups A and R. After induction, heart rate decreased significantly in all groups except in Group P. After intubation, haemodynamic responses were similar in the remifentanil, fentanyl and alfentanil groups and were within normal limits. In Group P, arterial pressures and heart rates were significantly higher. CONCLUSIONS: Alfentanil, fentanyl and remifentanil in the doses described had similar effects in controlling the haemodynamic response to tracheal intubation in ASA I-II morbidly obese patients.


Subject(s)
Anesthetics, Intravenous/pharmacology , Hemodynamics/drug effects , Intubation, Intratracheal , Obesity, Morbid/physiopathology , Alfentanil/pharmacology , Blood Pressure/drug effects , Fentanyl/pharmacology , Heart Rate/drug effects , Humans , Laryngoscopy , Piperidines/pharmacology , Remifentanil
6.
Obes Surg ; 11(4): 496-501, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11501363

ABSTRACT

BACKGROUND: The choice of anesthetic technique for general anesthesia in morbidly obese patients remains controversial. We aimed to compare blood gases, recovery and hemodynamic parameters using TIVA and sevoflurane anesthesia in bariatric surgery. METHODS: The study was performed with permission of the ethics committee. We studied 40 morbidly obese patients allocated to 2 groups. The total i.v. anesthesia (TIVA) group was named Group T, and the sevoflurane group was named Group S. In Group T, anesthesia induction was achieved with propofol. In Group S, anesthesia induction was achieved by sevoflurane with single breath technique, with maintenance provided with 1-2% volume sevoflurane. Student t, Chi square and ANOVA tests were used for data analysis; p-value < 0.05 was considered statistically significant. RESULTS: There was no significant difference between the 2 groups in demographic data, blood gas values and recovery characteristic. Hemodynamic values were significantly lower in Group T than Group S, during and after the operative period. CONCLUSION: While sevoflurane induction and maintenance is a suitable anesthetic modality for obese patients, TIVA can be applied easily in those patients possessing no extra risk factors other than morbid obesity.


Subject(s)
Alfentanil/therapeutic use , Anesthesia, Inhalation/methods , Anesthesia, Intravenous/methods , Anesthetics, Inhalation/therapeutic use , Anesthetics, Intravenous/therapeutic use , Gastroplasty , Methyl Ethers/therapeutic use , Obesity, Morbid/surgery , Propofol/therapeutic use , Adult , Analysis of Variance , Anesthesia Recovery Period , Anesthesia, Inhalation/adverse effects , Anesthesia, Intravenous/adverse effects , Blood Gas Analysis , Chi-Square Distribution , Drug Therapy, Combination , Female , Hemodynamics , Humans , Male , Middle Aged , Obesity, Morbid/metabolism , Obesity, Morbid/physiopathology , Risk Factors , Sevoflurane , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL